Cargando…

Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays

Androgen receptor (AR) is a ligand-activated transcription factor that plays a pivotal role in the development and progression of many severe diseases such as prostate cancer, muscle atrophy, and osteoporosis. Binding of ligands to AR triggers the conformational changes in AR that may affect the rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wenfang, Duan, Mojie, Fu, Weitao, Pang, Jinping, Tang, Qin, Sun, Huiyong, Xu, Lei, Chang, Shan, Li, Dan, Hou, Tingjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411960/ https://www.ncbi.nlm.nih.gov/pubmed/30639122 http://dx.doi.org/10.1016/j.gpb.2018.03.007

Ejemplares similares

Discovery of Novel ROCK1 Inhibitors via Integrated Virtual Screening Strategy and Bioassays
por: Shen, Mingyun, et al.
Publicado: (2015)

Discovery of Novel GR Ligands toward Druggable GR Antagonist Conformations Identified by MD Simulations and Markov State Model Analysis
por: Hu, Xueping, et al.
Publicado: (2021)

Discovery of a novel nonsteroidal selective glucocorticoid receptor modulator by virtual screening and bioassays
por: Pang, Jin-ping, et al.
Publicado: (2022)

Constructing and Validating High-Performance MIEC-SVM Models in Virtual Screening for Kinases: A Better Way for Actives Discovery
por: Sun, Huiyong, et al.
Publicado: (2016)

Virtual screening of bioassay data
por: Schierz, Amanda C
Publicado: (2009)

In Silico Exploration for Novel Type-I Inhibitors of Tie-2/TEK: The Performance of Different Selection Strategy in Selecting Virtual Screening Candidates
por: Pan, Peichen, et al.
Publicado: (2016)

The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay
por: Xia, Jie, et al.
Publicado: (2018)

Discovery of human TyrRS inhibitors by structure-based virtual screening, structural optimization, and bioassays
por: Huang, Shenzhen, et al.
Publicado: (2019)

In Vitro Androgen Bioassays as a Detection Method for Designer Androgens
por: Cooper, Elliot R., et al.
Publicado: (2013)

Virtual Screening of Chemical Compounds for Discovery of Complement C3 Ligands
por: Mohan, Rohith R., et al.
Publicado: (2018)

Discovering novel chemical inhibitors of human cyclophilin A: Virtual screening, synthesis, and bioassay
por: Li, Jian, et al.
Publicado: (2006)

Discovery of High-Affinity Amyloid Ligands Using a Ligand-Based Virtual Screening Pipeline
por: Chisholm, Timothy S., et al.
Publicado: (2023)

ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling
por: Lei, Tailong, et al.
Publicado: (2016)

The Observation of Ligand-Binding-Relevant Open States of Fatty Acid Binding Protein by Molecular Dynamics Simulations and a Markov State Model
por: Guo, Yue, et al.
Publicado: (2019)

CovalentInDB: a comprehensive database facilitating the discovery of covalent inhibitors
por: Du, Hongyan, et al.
Publicado: (2020)

Combined Ligand/Structure-Based Virtual Screening and Molecular Dynamics Simulations of Steroidal Androgen Receptor Antagonists
por: Wang, Yuwei, et al.
Publicado: (2017)

Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques
por: Noha, Stefan M., et al.
Publicado: (2011)

Discovery of Novel CCR5 Ligands as Anticolorectal Cancer Agents by Sequential Virtual Screening
por: El-Zohairy, Mariam A., et al.
Publicado: (2021)

Predicting the mutation effects of protein–ligand interactions via end-point binding free energy calculations: strategies and analyses
por: Yu, Yang, et al.
Publicado: (2022)

Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist
por: Rupp, Matthias, et al.
Publicado: (2010)

When drug discovery meets web search: Learning to Rank for ligand-based virtual screening
por: Zhang, Wei, et al.
Publicado: (2015)

Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors
por: Al-Sanea, Mohammad M., et al.
Publicado: (2022)

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
por: Jang, Cheongyun, et al.
Publicado: (2018)

Small-Molecule Inhibition of Androgen Receptor Dimerization as a Strategy against Prostate Cancer
por: Fu, Weitao, et al.
Publicado: (2023)

Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches
por: Vázquez, Javier, et al.
Publicado: (2020)

Lead Discovery Using Virtual Screening
por: Bikker, Jack Andrew, et al.
Publicado: (2009)

Promising Aedes aegypti Repellent Chemotypes Identified through Integrated QSAR, Virtual Screening, Synthesis, and Bioassay
por: Oliferenko, Polina V., et al.
Publicado: (2013)

Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation
por: Xu, Yijie, et al.
Publicado: (2023)

Bioassay-guided discovery of antibacterial agents: in vitro screening of Peperomia vulcanica, Peperomia fernandopoioana and Scleria striatinux
por: Mbah, James A, et al.
Publicado: (2012)

In Vitro Biologic Activities of the Antimicrobials Triclocarban, Its Analogs, and Triclosan in Bioassay Screens: Receptor-Based Bioassay Screens
por: Ahn, Ki Chang, et al.
Publicado: (2008)

Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
por: Stein, Reed M., et al.
Publicado: (2020)

A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists
por: Bovee, Toine F. H., et al.
Publicado: (2007)

The BioAssay network and its implications to future therapeutic discovery
por: Zhang, Jintao, et al.
Publicado: (2011)

Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17β-Hydroxysteroid Dehydrogenase 2 Inhibitors
por: Vuorinen, Anna, et al.
Publicado: (2014)

Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
por: Pal, Sourav, et al.
Publicado: (2019)

BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
por: Visser, Ubbo, et al.
Publicado: (2011)

Correction: Promising Aedes aegypti Repellent Chemotypes Identified through Integrated QSAR, Virtual Screening, Synthesis, and Bioassay
por: Oliferenko, Polina V., et al.
Publicado: (2014)

Virtual ligand screening: strategies, perspectives and limitations
por: Klebe, Gerhard
Publicado: (2006)

The OECD Program to Validate the Rat Hershberger Bioassay to Screen Compounds for in Vivo Androgen and Antiandrogen Responses: Phase 2 Dose–Response Studies
por: Owens, William, et al.
Publicado: (2007)

Virtual Screening in Lead Discovery: A Viewpoint†
por: Oprea, Tudor Ionel
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_oi6kvp11dgqnr0r16a4dheqc4e